Why is teladoc going down?

What happened. Shares of Teladoc Health (TDOC 3.57%) went down in flames on Thursday, plunging as much as 47.8%. At 10:28 a.m. ET, the stock was down 46.3%. The catalyst that sent the digital healthcare company plummeting was first-quarter financial results that were far worse than investors had anticipated.

Why are Teladoc stock dropping?

Teladoc stock fell in after-hours trading Tuesday after the telehealth giant posted fourth-quarter earnings, despite results exceeding Wall Street's expectations on profit and revenue.

Is Teladoc going under?

Shares of struggling telehealth company Teladoc Health (TDOC 4.03%) collapsed after it recently released earnings for the first quarter of 2022. After shooting to roughly $300 per share in early 2021, the stock sits at just under $40, a staggering decline of more than 80%.

Will Teladoc ever recover?

Despite the stock's steady decline over the past year, Teladoc Health still holds a promising future due to its disruptive model. According to Tulane University School of Public Health and Tropical Medicine, Telemedicine is here to stay for the foreseeable future.

Is Teladoc still a good buy?

Teladoc Health, Inc. (NYSE:TDOC) delivered a -39.02% return since the beginning of the year, while its 12-month returns are down by -67.23%. The stock closed at $55.99 per share on April 25, 2022. "Teladoc is the largest telehealth provider in the US and has recently begun to expand internationally.

Teladoc CRASHES! Is It Coming Back?

Is Teladoc undervalued?

The revenue per member was reported $2.32 in 2021, up from $1.12 in 2020. I believe Teladoc's stock price is undervalued based on relative valuation indicators. The stock's price-to-sales ratio hit below 4 in mid-March (lowest since 2016) and is trading at 5.33, while the price-to-book ratio is at 0.69.

Is TDOC overvalued?

Valuation metrics show that Teladoc Health, Inc. may be overvalued. Its Value Score of D indicates it would be a bad pick for value investors. The financial health and growth prospects of TDOC, demonstrate its potential to underperform the market.

Who are teladoc competitors?

Teladoc Health's top competitors include naviHealth, Lash Group, Amwell, 98point6, MDLIVE, Providence Service Corporation and Sharecare. Teladoc Health is a telehealth company that uses telephone and video conferencing technology to provide on-demand remote medical care via mobile devices, the internet, and video.

Is TDOC buy or sell?

The consensus among 27 Wall Street analysts covering (NYSE: TDOC) stock is to Buy TDOC stock.

What was teladoc IPO price?

Telehealth platform company Teladoc, on Tuesday, announced that its initial public offering would be priced at $19 per share, raising $157 million, according to a Renaissance Capital post to NASDAQ.com.

Will Teladoc ever be profitable?

The telehealth giant isn't yet profitable and reported a loss of $84.3 million in the third quarter of 2021, deeper than its year-prior loss of $36 million. Shares of Teladoc stock fell 6.2% on Monday as of 10:47 a.m. in New York.

What is Nio price target?

Stock Price Forecast

The 31 analysts offering 12-month price forecasts for NIO Inc have a median target of 30.38, with a high estimate of 66.84 and a low estimate of 21.94. The median estimate represents a +31.62% increase from the last price of 23.08.

Is Teladoc owned by Aetna?

Teladoc and Teladoc physicians are independent contractors and are not agents of Aetna. For a complete description of the limitations of Teladoc services, visit Teladoc.com/Aetna. Teladoc, Teladoc Health and the Teladoc Health logo are registered trademarks or trademarks of Teladoc Health, Inc.

How does Teladoc make money?

How does Teladoc Make Money? Teladoc's major revenue source is from the subscription-based model. Patients pay annual or monthly fees for consultation. The subscription-based plan starts from $49, they also sell services to clients on behalf of their employees.

Is Teladoc a big company?

Teladoc (NYSE: TDOC) is one of the largest companies in the telemedicine space, expanding its reach with the acquisition of Livongo in 2020. Teladoc forecasts revenue growth of between $367 million to $467 million by the end of 2022 with total visits expected to rise between 20% and 27% from 15.4 million a year ago.

Did teladoc overpay for Livongo?

Telehealth giant Teladoc completed its massive $18.5 billion acquisition of Livongo, the company announced Friday.

Is docu a buy?

The sell-side's consensus sales increase estimate for DOCU in Q1 FY 2023 is +24.0% (versus +23.9% for management guidance); and the analysts see DocuSign generating a revenue growth of +17.6% for full-year fiscal 2023 (versus management's expectations of +17.5%).

What do analysts say about teladoc?

Teladoc Health Inc (NYSE:TDOC)

The 24 analysts offering 12-month price forecasts for Teladoc Health Inc have a median target of 43.50, with a high estimate of 141.00 and a low estimate of 30.00. The median estimate represents a +21.61% increase from the last price of 35.77.

Will Etsy go up?

The 18 analysts offering 12-month price forecasts for ETSY Inc have a median target of 127.50, with a high estimate of 268.00 and a low estimate of 75.00. The median estimate represents a +72.04% increase from the last price of 74.11.

How much TDOC does Ark own?

Altogether, ARK owns 12% of Teladoc's outstanding shares, according to Bloomberg. The crash in TDOC couldn't have come at a worse time for ARK. The issuer's ETFs were already reeling from a yearlong bear market in high growth stocks.

What ETF is teladoc in?

Teladoc Health, Inc. is a company in the U.S. stock market and it is a holding in 118 U.S.-traded ETFs. TDOC has around 27.7M shares in the U.S. ETF market. The largest ETF holder of TDOC is the ARK Innovation ETF (ARKK), with approximately 11.78M shares.